International Health Committee

Chair David M. Lewinsohn, MD, PhD Portland, OR
Vice Chair Samya Z. Nasr, MD, ATSF Ann Arbor, MI
Committee Member Alejandro Casas BOGOTA, CUNDINAMARCA, Colombia
Committee Member Enrico Lombardi, MD Florence, Florence, Italy
Committee Member Esther Barreiro, MD, PhD Barcelona, CATALONIA, Spain
Committee Member Jeremiah Chakaya, MD Nairobi, Nairobi, Kenya
Committee Member Kiyoyasu Kurahashi, MD, PhD, ATSF Narita, Chiba, Japan
Committee Member Kwun M. Fong, MBBS, PhD Brisbane, Queensland, Australia
Committee Member Marcus Barreto B. Conte, MD Petropolis - 25755-340, Rio de Janeiro, Brazil
Committee Member Obianuju B. Ozoh, MBBS, ATSF Lagos, Lagos, Nigeria
Committee Member Payam Nahid, MD, MPH San Francisco, CA
Committee Member Peggy S. Lai, MPH, MD, ATSF Boston, MA
Committee Member Priya B. Shete, MD, MPH San Francisco, CA
Committee Member Richard N. Van Zyl Smit, MBChB, PhD, ATSF Cape Town, western Cape, South Africa
Committee Member - MECOR Steering Committee Chair Shannon S. Carson, MD Chapel Hill, NC
Committee Member Stephan Schwander, MD, PhD Piscataway, NJ
Committee Member Timothy E. West, MD, MPH Seattle, WA
Committee Member William Checkley, MD, PhD Baltimore, MD
Staff Cristina Braz New York, NY
Staff Karen J. Collishaw New York, NY
Staff Benjamin Lesiak New York, NY

The International Health Committee develops strategies to promote the global mission of the ATS to improve the health of patients worldwide with pulmonary and sleep‐related conditions and critical illnesses. It recommends to the Board policies, guidelines, and programs that promote lung health worldwide as well as enhance care of the critically ill and those with sleep disorders worldwide. The Committee coordinates and facilitates the interactions of the Society with professional organizations based outside of the United States. It also provides oversight for programs and partnerships co‐ sponsored or endorsed by the ATS but initiated or managed by international, governmental, and non‐ governmental organizations and agencies. The Committee also advises the Executive Committee regarding participation of ATS officers in programs sponsored by international organizations and works in collaboration with the Research Advocacy Committee to advocate for international research funding. It will review, revise and implement an annual plan for the promotion of the Society’s Strategic Directions for Global Health that describes the activities and programs to achieve the aims of the Society in global health.

Benchmarks, 2021-2022:
• Implementation of Task Force recommendations through development of the following working groups: 1) Global Health Roadmap Working Group; 2) Global Health Policy Working Group; 3) MECOR Steering Committee; 4) International Conference & Education Working Group; 5) Global Health Dashboard Working Group, and 6) IHC Grant Working Group.
• Develop Global Health Roadmap and finalize the document at Leadership Summit 2022.
• Develop and launch ATS IHC International Health Forum.
• Continue development of the 2022 5-year MECOR Strategic Plan. Priority areas include: Faculty and Student Development, Alumni Engagement, Curriculum, and Growth Strategies. Final document to be finalized at in-person meeting January 2022.
• Continue to promote the MECOR research award program and develop additional funding mechanisms. Develop additional fundraising opportunities in collaboration with the Funds For the Future Committee.
• Evaluate existing relationships with peer organizations to generate value for international members.
• Continue to organize and implement the ATS International Scholarship Program and the MECOR Scholarship Program.
• Continue to organize and host the International Scholars Poster Colloquium, either in-person or virtually. Work with the Task force on Designing Future ATS Conferences to ensure the recommendations are aligned.